Publications

September 30, 2022

Potential of PVRIG and TIGIT blockade in addressing immunotherapy resistance

Eran Ophir, Immuno UK, London, UK, 30 September 2022

June 28, 2022

PVRIG and TIGIT immune checkpoint blockade in cancer: Emerging translational data from clinical trials

Pierre Ferré, AIS 2022 Montpellier, France, 28 June 2022

December 9, 2021

Harnessing PVRIG & TIGIT Combination in Anti-Cancer Immunity

Eran Ophir, VP Research & Drug Discovery, TIGIT Therapies Digital Summit

June 29, 2021

The TIGIT Pathway, PVRIG, a Novel Pathway Member, Targets for Cancer Immunotherapy: A Deep Dive

Eran Ophir, VP Research and Drug Discover June 2021.

Scroll to Top